BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12571201)

  • 21. Feasibility of dual-isotope coincidence/single-photon imaging of the myocardium.
    Di Bella EV; Kadrmas DJ; Christian PE
    J Nucl Med; 2001 Jun; 42(6):944-50. PubMed ID: 11390561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Simultaneous assessment of myocardial perfusion and ventricular function using thallium-201 at rest/Tc-99m tetrofosmin at effort with single-photon emission computerized tomography, synchronized with electrocardiogram (synchronized SPECT). Initial experience in Latin America].
    Puente A; Alexánderson E; Arroyo A; Lorenzo A; Victoria D
    Arch Inst Cardiol Mex; 2000; 70(5):448-55. PubMed ID: 11534095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial changes in glucose-loaded 18F-fluoro-2-deoxyglucose positron emission tomography, 99mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl-penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction.
    Fukuoka R; Horita Y; Namura M; Ikeda M; Terai H; Tama N; Takagi T; Bunko H
    Circ J; 2013; 77(1):137-45. PubMed ID: 23037521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
    Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
    Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
    Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
    J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
    Roes SD; Kaandorp TA; Marsan NA; Westenberg JJ; Dibbets-Schneider P; Stokkel MP; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
    Gratz S; Kempke B; Kaiser W; Behr TM; Pfestroff A; Höffken H
    Nucl Med Commun; 2008 Nov; 29(11):963-9. PubMed ID: 18836374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability.
    Schinkel AF; Bax JJ; Biagini E; Elhendy A; van Domburg RT; Valkema R; Rizzello V; Schouten O; Simoons M; Poldermans D
    Am J Cardiol; 2005 May; 95(10):1223-5. PubMed ID: 15877995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT) and metabolism (F-18-FDG-PET)].
    Schäfer WM; Nowak B; Kaiser HJ; Block S; Koch KC; vom Dahl J; Büll U
    Nuklearmedizin; 2001 Oct; 40(5):164-71. PubMed ID: 11727629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; Jager PL
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):63-80. PubMed ID: 16372139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.
    Shirasaki H; Nakano A; Uzui H; Yonekura Y; Okazawa H; Ueda T; Lee JD
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):879-86. PubMed ID: 16586079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
    Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
    Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.
    Arun S; Mittal BR; Bhattacharya A; Rohit MK
    J Nucl Cardiol; 2015 Feb; 22(1):98-110. PubMed ID: 25124826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion.
    Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P
    J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
    J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
    Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
    Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT: comparison with Tl-201 stress-reinjection SPECT.
    Wu YW; Huang PJ; Lee CM; Ho YL; Lin LC; Wang TD; Wang SS; Chen TH; Yen RF
    J Nucl Cardiol; 2005; 12(4):451-9. PubMed ID: 16084434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.